Merck Animal Health

Merck Animal Health. It is the animal health division of the multinational pharmaceutical corporation Merck & Co., dedicated to the research, development, and manufacturing of veterinary medicines, vaccines, and health management solutions. The division operates globally, providing products for a wide range of species including companion animals, livestock, and poultry. Its mission focuses on advancing the science of animal health to improve the well-being of animals and support the veterinarians and farmers who care for them.

History

The origins of the division trace back to 1953 with the establishment of MSD AGVET, a dedicated animal health unit within Merck & Co.. A significant expansion occurred in 2009 when Merck & Co. merged with Schering-Plough, integrating the robust animal health assets of Intervet, a legacy Schering-Plough company with deep roots in the Netherlands. This merger created one of the world's largest animal health businesses, later rebranded as Merck Animal Health in 2011. Further strategic growth was achieved through acquisitions, including the 2014 purchase of the aqua health business from Harrisvaccines and the 2018 acquisition of Antelliq Group, a leader in digital identification and monitoring technology. These moves have consistently positioned the company at the forefront of the global animal health industry.

Products and services

The company's portfolio is extensive, encompassing biologicals, pharmaceuticals, and technology-based services. Key product areas include vaccines for diseases such as canine distemper, bovine respiratory disease, and avian influenza, as well as parasiticides like Bravecto for flea and tick control. It also offers a wide array of antimicrobial and anti-inflammatory drugs for therapeutic use. A major service pillar is its digital and data analytics offerings, provided through the Allflex and SenseHub brands, which include ear tags, rumination monitors, and tracking systems that support precision livestock farming. These tools are used by producers worldwide, from dairy farms in the United States to beef cattle ranches in Brazil.

Research and development

Research and development activities are central to the company's strategy, conducted through a network of facilities including major sites in Madison, New Jersey, Boxmeer, and Kansas City. Its R&D pipeline focuses on innovative solutions in areas such as infectious disease prevention, parasitology, and therapeutics, often leveraging advanced platforms like recombinant DNA technology. The division collaborates extensively with external partners, including academic institutions like the University of Pennsylvania School of Veterinary Medicine and research organizations such as the Pirbright Institute. Notable recent innovations include the development of a porcine reproductive and respiratory syndrome (PRRS) vaccine and next-generation ectoparasiticides, reflecting a commitment to addressing pressing challenges in both companion animal and production animal health.

Corporate affairs

As a division of Merck & Co., it is headquartered in Rahway, New Jersey, and operates in over 50 countries, with significant manufacturing and research presence in Europe, North America, and Asia-Pacific. The division's president is Rick DeLuca, who reports into the parent company's executive leadership. It actively engages with global regulatory bodies, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), to ensure compliance and bring new products to market. The business is a major participant in industry events such as the World Veterinary Congress and is a member of trade associations like HealthforAnimals, advocating for policies that support veterinary medicine innovation and animal welfare.

Animal health initiatives

Beyond commercial products, the company runs several global health initiatives aimed at improving animal and public health. A flagship program is the African Livestock Productivity and Health Advancement (A.L.P.H.A.) initiative, launched in collaboration with the African Union and the United States Agency for International Development (USAID) to enhance veterinary care and food security on the continent. It also supports disease eradication efforts, contributing to campaigns against peste des petits ruminants and rabies in partnership with organizations like the World Organisation for Animal Health (WOAH). Furthermore, it provides educational resources and disaster relief support through partnerships with entities such as the American Veterinary Medical Association and the International Fund for Animal Welfare.

Category:Animal health companies Category:Merck & Co.